Cognitive and Memory Enhancer Drugs Market 2028 By Drug Type, Application and Geography | The Insight Partners

Cognitive and Memory Enhancer Drugs Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Adderall, Provigil, Razadyne, Aricept, Namenda, Ritalin, Exelon, Others); Application (Disease Treatment, Academic Performance, Athletic Performance, Others) and Geography

Report Code: TIPRE00003844 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

MARKET OVERVIEW



Cognitive and memory enhancers are the supplements or drugs, which assist to improve the cognitive functions such as creativity, memory, and others in patients suffering from diseases and disorders such as neurological disorders as well as in healthy individuals. The growth in the geriatric population, which is prone to neurological disorders such as Alzheimer's, is one of the primary drivers driving market growth. Furthermore, the market is expected to grow due to the increase in the usage of cognitive drugs due to their benefits, which include enhanced physical and mental performance.

MARKET SCOPE



The "Global Cognitive and Memory Enhancer Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cognitive and memory enhancer drugs market with detailed market segmentation by drug type and application. The report provides key statistics on the market status of the leading cognitive and memory enhancer drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on drug type the market is segmented as, aricept, razadyne, exelon, namenda, provigil, ritalin, adderall and others.
  • Based on application the market is segmented as, disease treatment, academic performance, athletic performance and others.

MARKET DYNAMICS


Drivers:



  • Increasing geriatric population and growing prevalence of people suffering from neurodegenerative diseases like Alzheimer's disease.
  • Moreover, the benefits offered by cognitive and memory enhancer drugs, such as enhanced physical and mental performance, are expected to fuel market growth.
  • Increased healthcare expenditures along with presence of robust pipeline of agents is also expected to spur the market growth during the forecast period.

Restraints:



  • However, ethical issues present with the use of such sort of drugs is expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cognitive and memory enhancer drugs market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cognitive and memory enhancer drugs market in these regions.

IMPACT OF COVID-19 ON COGNITIVE AND MEMORY ENHANCER DRUGS MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the cognitive and memory enhancer drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cognitive and memory enhancer drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for cognitive and memory enhancer drugs in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cognitive and memory enhancer drugs market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Eisai Co., Ltd.
  • Pfizer Inc
  • Johnson and Johnson Services, Inc
  • Alternascript
  • Lundbeck
  • Novartis AG
  • Lilly
  • Takeda Pharmaceutical Company Limited
  • F. Hoffmann-La Roche Ltd
  • Sanofi
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cognitive And Memory Enhancer Drugs Market - By Drug Type
1.3.2 Cognitive And Memory Enhancer Drugs Market - By Application
1.3.3 Cognitive And Memory Enhancer Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. COGNITIVE AND MEMORY ENHANCER DRUGS - GLOBAL MARKET OVERVIEW
6.2. COGNITIVE AND MEMORY ENHANCER DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ADDERALL
7.3.1. Overview
7.3.2. Adderall Market Forecast and Analysis
7.4. PROVIGIL
7.4.1. Overview
7.4.2. Provigil Market Forecast and Analysis
7.5. RAZADYNE
7.5.1. Overview
7.5.2. Razadyne Market Forecast and Analysis
7.6. ARICEPT
7.6.1. Overview
7.6.2. Aricept Market Forecast and Analysis
7.7. NAMENDA
7.7.1. Overview
7.7.2. Namenda Market Forecast and Analysis
7.8. RITALIN
7.8.1. Overview
7.8.2. Ritalin Market Forecast and Analysis
7.9. EXELON
7.9.1. Overview
7.9.2. Exelon Market Forecast and Analysis
7.10. OTHERS
7.10.1. Overview
7.10.2. Others Market Forecast and Analysis
8. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. DISEASE TREATMENT
8.3.1. Overview
8.3.2. Disease Treatment Market Forecast and Analysis
8.4. ACADEMIC PERFORMANCE
8.4.1. Overview
8.4.2. Academic Performance Market Forecast and Analysis
8.5. ATHLETIC PERFORMANCE
8.5.1. Overview
8.5.2. Athletic Performance Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis

9. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cognitive And Memory Enhancer Drugs Market Overview
9.1.2 North America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis
9.1.3 North America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Drug Type
9.1.4 North America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cognitive And Memory Enhancer Drugs Market
9.1.5.1.1 United States Cognitive And Memory Enhancer Drugs Market by Drug Type
9.1.5.1.2 United States Cognitive And Memory Enhancer Drugs Market by Application
9.1.5.2 Canada Cognitive And Memory Enhancer Drugs Market
9.1.5.2.1 Canada Cognitive And Memory Enhancer Drugs Market by Drug Type
9.1.5.2.2 Canada Cognitive And Memory Enhancer Drugs Market by Application
9.1.5.3 Mexico Cognitive And Memory Enhancer Drugs Market
9.1.5.3.1 Mexico Cognitive And Memory Enhancer Drugs Market by Drug Type
9.1.5.3.2 Mexico Cognitive And Memory Enhancer Drugs Market by Application
9.1.5.4 US Cognitive And Memory Enhancer Drugs Market
9.1.5.4.1 US Cognitive And Memory Enhancer Drugs Market by Drug Type
9.1.5.4.2 US Cognitive And Memory Enhancer Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Cognitive And Memory Enhancer Drugs Market Overview
9.2.2 Europe Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis
9.2.3 Europe Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cognitive And Memory Enhancer Drugs Market
9.2.5.1.1 Germany Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.1.2 Germany Cognitive And Memory Enhancer Drugs Market by Application
9.2.5.2 France Cognitive And Memory Enhancer Drugs Market
9.2.5.2.1 France Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.2.2 France Cognitive And Memory Enhancer Drugs Market by Application
9.2.5.3 Italy Cognitive And Memory Enhancer Drugs Market
9.2.5.3.1 Italy Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.3.2 Italy Cognitive And Memory Enhancer Drugs Market by Application
9.2.5.4 Spain Cognitive And Memory Enhancer Drugs Market
9.2.5.4.1 Spain Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.4.2 Spain Cognitive And Memory Enhancer Drugs Market by Application
9.2.5.5 United Kingdom Cognitive And Memory Enhancer Drugs Market
9.2.5.5.1 United Kingdom Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.5.2 United Kingdom Cognitive And Memory Enhancer Drugs Market by Application
9.2.5.6 Rest of Europe Cognitive And Memory Enhancer Drugs Market
9.2.5.6.1 Rest of Europe Cognitive And Memory Enhancer Drugs Market by Drug Type
9.2.5.6.2 Rest of Europe Cognitive And Memory Enhancer Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cognitive And Memory Enhancer Drugs Market Overview
9.3.2 Asia-Pacific Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cognitive And Memory Enhancer Drugs Market
9.3.5.1.1 Australia Cognitive And Memory Enhancer Drugs Market by Drug Type
9.3.5.1.2 Australia Cognitive And Memory Enhancer Drugs Market by Application
9.3.5.2 China Cognitive And Memory Enhancer Drugs Market
9.3.5.2.1 China Cognitive And Memory Enhancer Drugs Market by Drug Type
9.3.5.2.2 China Cognitive And Memory Enhancer Drugs Market by Application
9.3.5.3 India Cognitive And Memory Enhancer Drugs Market
9.3.5.3.1 India Cognitive And Memory Enhancer Drugs Market by Drug Type
9.3.5.3.2 India Cognitive And Memory Enhancer Drugs Market by Application
9.3.5.4 Japan Cognitive And Memory Enhancer Drugs Market
9.3.5.4.1 Japan Cognitive And Memory Enhancer Drugs Market by Drug Type
9.3.5.4.2 Japan Cognitive And Memory Enhancer Drugs Market by Application
9.3.5.5 Rest of Asia-Pacific Cognitive And Memory Enhancer Drugs Market
9.3.5.5.1 Rest of Asia-Pacific Cognitive And Memory Enhancer Drugs Market by Drug Type
9.3.5.5.2 Rest of Asia-Pacific Cognitive And Memory Enhancer Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cognitive And Memory Enhancer Drugs Market Overview
9.4.2 Middle East and Africa Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cognitive And Memory Enhancer Drugs Market
9.4.5.1.1 South Africa Cognitive And Memory Enhancer Drugs Market by Drug Type
9.4.5.1.2 South Africa Cognitive And Memory Enhancer Drugs Market by Application
9.4.5.2 Saudi Arabia Cognitive And Memory Enhancer Drugs Market
9.4.5.2.1 Saudi Arabia Cognitive And Memory Enhancer Drugs Market by Drug Type
9.4.5.2.2 Saudi Arabia Cognitive And Memory Enhancer Drugs Market by Application
9.4.5.3 U.A.E Cognitive And Memory Enhancer Drugs Market
9.4.5.3.1 U.A.E Cognitive And Memory Enhancer Drugs Market by Drug Type
9.4.5.3.2 U.A.E Cognitive And Memory Enhancer Drugs Market by Application
9.4.5.4 Rest of Middle East and Africa Cognitive And Memory Enhancer Drugs Market
9.4.5.4.1 Rest of Middle East and Africa Cognitive And Memory Enhancer Drugs Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa Cognitive And Memory Enhancer Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cognitive And Memory Enhancer Drugs Market Overview
9.5.2 South and Central America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis
9.5.3 South and Central America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cognitive And Memory Enhancer Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cognitive And Memory Enhancer Drugs Market
9.5.5.1.1 Brazil Cognitive And Memory Enhancer Drugs Market by Drug Type
9.5.5.1.2 Brazil Cognitive And Memory Enhancer Drugs Market by Application
9.5.5.2 Argentina Cognitive And Memory Enhancer Drugs Market
9.5.5.2.1 Argentina Cognitive And Memory Enhancer Drugs Market by Drug Type
9.5.5.2.2 Argentina Cognitive And Memory Enhancer Drugs Market by Application
9.5.5.3 Rest of South and Central America Cognitive And Memory Enhancer Drugs Market
9.5.5.3.1 Rest of South and Central America Cognitive And Memory Enhancer Drugs Market by Drug Type
9.5.5.3.2 Rest of South and Central America Cognitive And Memory Enhancer Drugs Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. COGNITIVE AND MEMORY ENHANCER DRUGS MARKET, KEY COMPANY PROFILES
11.1. EISAI CO., LTD.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOHNSON AND JOHNSON SERVICES, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ALTERNASCRIPT
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. LUNDBECK
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVARTIS AG
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. LILLY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. F. HOFFMANN-LA ROCHE LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SANOFI
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
"
The List of Companies

1. Eisai Co., Ltd.
2. Pfizer Inc
3. Johnson and Johnson Services, Inc
4. Alternascript
5. Lundbeck
6. Novartis AG
7. Lilly
8. Takeda Pharmaceutical Company Limited
9. F. Hoffmann-La Roche Ltd
10. Sanofi
TIPRE00003844
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount